8-K current report · filed Nov 12, 2026

Anteris Technologies Global Corp. (AVR) 8-K Current Report: November 12, 2026

Item 2.02Item EX-99.1Item EX-99.2AVR overview

Short answer

Anteris Technologies Global Corp. (AVR) filed an 8-K current report with the SEC on November 12, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1), Item EX-99.2 (Exhibit EX-99.2). Q3 2026 financial results for quarter ended September 30, 2026.

Anteris Technologies Global Corp. 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Q3 2026 financial results for quarter ended September 30, 2026
  • Form 10-Q filed with ASX on November 10, 2026, U.S. time
  • Unaudited historical financial information available in Exhibits 99.1 and 99.2

Item EX-99.1 · Exhibit EX-99.1

  • Q3 2026 reporting period covered by the filed Form 10-Q and ASX quarterly disclosure
  • Related-party payments totaled US$576,000, including executive salaries and non-executive director fees
  • All related-party payments flowed through operating activities, with none included in investing activities
  • Investors should review the Form 10-Q and November 11, 2026 results announcement for operating and financial performance

Item EX-99.2 · Exhibit EX-99.2

  • Q3 2026 operating cash outflows $22.9M, highlighting substantial funding needs during pivotal-trial execution
  • R&D expense $21.3M, driven by PARADIGM enrollment, manufacturing scale-up, quality validation and expanded clinical staffing
  • PARADIGM Trial expanding across the U.S., Canada and Europe, with Germany and Australia added after quarter-end
  • Northcross facility occupancy expands DurAVR THV and ComASUR production capacity ahead of potential commercialization
  • Trial targets approximately 1,000 patients, testing DurAVR against commercial TAVRs on a one-year composite endpoint

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Anteris Technologies Global Corp. 8-K filings

Get the next AVR 8-K as it lands

Follow AVR for push alerts, or ask the research agent what this filing means.